logo

For the Inventor, By the Inventor

High Point, NC, United States of America

High Point Pharmaceuticals, LLC


USPTO Granted Patents = 50



Forward Citations = 208

Loading Chart...
Loading Chart...

58 inventors (with patents filed for the assignee):

goldMedal Soren Ebdrup (14 out of 23 patents)

silverMedal Adnan M M Mjalli (11 out of 74 patents)

bronzeMedal Henrik Sune Andersen (9 out of 63 patents)

4.  Dharma Rao Polisetti (8 out of 52 patents)

5.  Robert Carl Andrews (8 out of 53 patents)

6.  Per Sauerberg (7 out of 98 patents)

7.  Bapu Reddy Gaddam (7 out of 19 patents)

8.  Rolf Hohlweg (7 out of 55 patents)

9.  Ingrid Pettersson (6 out of 30 patents)

10.  Mohan Rao (6 out of 11 patents)

11.  Tan Ren (6 out of 7 patents)

12.  Jane Marie Lundbeck (6 out of 24 patents)

13.  Pavel Pihera (5 out of 11 patents)

14.  Miroslav Havranek (5 out of 14 patents)

15.  Gita Camilla Tejlgaard Kampen (5 out of 7 patents)


Core Competencies:
Benzazole Derivatives
Beta-Secretase Inhibitors
11-Beta-Hydroxysteroid Dehydrogenase
Tricyclic Compounds
PPAR Delta Activators
Histamine H3 Receptor Antagonists
Substituted Imidazole Derivatives
Heterocyclic H3 Antagonists
Indole Amides
Benzothiazoles
Obesity Treatment
Combination Therapy

50 patents:

1. 8946259 - Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors (2015-02-03),
2. 8927549 - Adamantyl benzamide derivatives (2015-01-06),
3. 8907096 - N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenase (2014-12-09),
4. 8853226 - Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors (2014-10-07),
5. 8846677 - Medicaments (2014-09-30),
6. 8809540 - N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase (2014-08-19),
7. 8772285 - Benzothiazoles having histamine H3 receptor activity (2014-07-08),
8. 8759535 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof (2014-06-24),
9. 8598353 - Benzazole derivatives, compositions, and methods of use as β-secretase inhibitors (2013-12-03),
10. 8563742 - Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use (2013-10-22),
11. 8551993 - Phenoxy acetic acids as PPAR delta activators (2013-10-08),
12. 8513430 - Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta HSD1 modulators (2013-08-20),
13. 8501739 - Medicaments (2013-08-06),
14. 8450354 - Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as β-secretase inhibitors (2013-05-28),
15. 8426473 - Phenoxy acetic acids as PPAR delta activators (2013-04-23),
High Point Pharmaceuticals, LLC is a leading pharmaceutical company specializing in the discovery, development, and commercialization of innovative healthcare solutions. With a focus on improving patient care, our dedicated team works tirelessly to bring effective and accessible treatments to individuals worldwide. Through cutting-edge research, strategic collaborations, and a commitment to excellence, we aim to transform the landscape of medicine and positively impact the lives of millions.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

50 Patents

#4 in High Point, NC

#158 in North Carolina

#6,767 in US

#13,583 in the World

...
High Point, NC, United States of America

High Point Pharmaceuticals, LLC

Forward Citations = 208

58 inventors:

goldMedal Soren Ebdrup (14 out of 23 patents)

silverMedal Adnan M M Mjalli (11 out of 74 patents)

bronzeMedal Henrik Sune Andersen (9 out of 63 patents)

4.  Dharma Rao Polisetti (8 out of 52 patents)

5.  Robert Carl Andrews (8 out of 53 patents)

Please report any incorrect information to support@idiyas.com
Loading…